Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1900606	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs	Supplementary Application	2019-05-27	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2019-08-12	view
JXHB2101021	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2021-06-02					view
JXHL1900196	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2019-08-27	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2019-08-26	view
JXHB2000021	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2020-09-03	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2020-09-02	view
JXHL1800190	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2018-12-29	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2018-12-28	view
JXHB2000020	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2020-09-03	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2020-09-02	view
JXHL1800189	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Import Drug Application	2018-12-29	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2018-12-28	view
JXHB2101093	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2021-11-11					view
JYHB1900607	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs	Supplementary Application	2019-05-27	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2019-08-12	view
JXHB2200067	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2022-06-08					view
JYHB2000737	PF-06651600片	ritlecitinib	Tablet	Chemical Drugs	Supplementary Application	2020-06-13	辉瑞投资有限公司	Pfizer Investment Co Ltd	In Review	2020-06-23	view